MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202411104749 A) filed by Akums Drugs & Pharmaceuticals Limited on December 30, 2024, for An Ophthalmic Composition Of Latanoprost And Netarsudil.
Inventor includes Jain Sanjeev.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention provides an ophthalmic composition of latanoprost or its salts and Netarsudil or its salts together with acceptable excipients. In particular the composition is an improved, effective and well tolerated an aqueous ophthalmic solution comprising Netarsudil mesylate and Latanoprost. The ophthalmic solution is used in the treatment of conditions of the eye such as lowering in open-angle glaucoma (OAG) or ocular hypertension (OHTN).
Disclaimer: Curated by HT Syndication.
